Title: Simultaneity of Tuberculosis and CLL : A Case Report

Manuscript title:

Introductionsince march 11, 2020 world health organization (WHO) reported a worldwide pandemic occurring by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) (1, 2). COVID-19 infections symptoms includes a variation of fever, cough, dyspnea, headache, myalgia and abdominal pain (3).Since then, there were reports of coinfections or misdiagnoses of covid-19 with other infections which have the same clinical or paraclinical symptoms (4, 5). Leptospirosis is a common infection in Southeast Asia and is one of those infections which can have the same symptoms as COVID-19 including cough and myalgia (6). In this study we are reporting a case that was not surely a severe pulmonary leptospirosis or covid-19.

We hereby, present the first case of Acute generalized exanthematous pustulosis (AGEP) following treatment with remdesivir in a patient with COVID-19 without hydroxychloroquine use which serves as a reminder for considering remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.

Although the presence of morphea following COVID-19 has been rarely reported, development of its generalized form following COVID-19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID-19 vaccination and another similar case following SARS-Cov-2 infection. Other etiologic factors were also dealt with